Lantus SoloStar 100 units/ml solution for injection in a pre-filled pen, insulin icodec 700 U/mL PDS290
NN1436-7724
Phase 3 small_molecule active
Quick answer
Lantus SoloStar 100 units/ml solution for injection in a pre-filled pen, insulin icodec 700 U/mL PDS290 for Type 2 Diabetes is a Phase 3 program (small_molecule) at Novo Nordisk A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novo Nordisk A/S
- Indication
- Type 2 Diabetes
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active